Affix Labs Secures €1 Million for Sustainable Insect Repellent Development in Europe
Affix Labs Group B.V., a pioneering startup in the Dutch Green Chemtech sector, has successfully secured €1 million in funding to expedite the launch of its flagship product, Repeltec, throughout Europe. This funding round was predominantly led by VP Capital and Oost NL, and it aims to significantly expand Affix Labs' market presence amidst increasingly stringent European pesticide regulations.
Repeltec is not your typical insect repellent; it utilizes a revolutionary formulation technique that enables the dissolution of oil-based active substances in water, eliminating the need for neurotoxic components. This feature addresses the growing resistance among insects against conventional pesticides. In a market where neurotoxicity is becoming an unaccepted standard, the unique water-based solution of Repeltec positions Affix Labs as a frontrunner in environmentally-conscious pest control.
What sets Repeltec apart further is its patented method for controlled release, ensuring the product remains effective for a duration of up to twelve weeks. Moreover, it has undergone dermatological testing to ensure user safety — a significant concern for consumers who are increasingly looking for non-toxic alternatives.
The timing of this financial bolstering is critical, as the European regulatory landscape for pesticides continues to grow more rigid. The recent ban on certain neurotoxic insecticides in Germany marks a pivotal shift towards stricter guidelines, and similar measures are rolling out across other EU member states. Affix Labs has already secured active substance approvals in several countries including Germany, France, Austria, and Norway. The financial support will facilitate a strategic expansion into these key markets, with plans to subsequently penetrate the markets in the UK and Poland.
In addition to its retail consumer products, Affix Labs is also set to introduce a B2B strategy under the brand
Repeltec is not your typical insect repellent; it utilizes a revolutionary formulation technique that enables the dissolution of oil-based active substances in water, eliminating the need for neurotoxic components. This feature addresses the growing resistance among insects against conventional pesticides. In a market where neurotoxicity is becoming an unaccepted standard, the unique water-based solution of Repeltec positions Affix Labs as a frontrunner in environmentally-conscious pest control.
What sets Repeltec apart further is its patented method for controlled release, ensuring the product remains effective for a duration of up to twelve weeks. Moreover, it has undergone dermatological testing to ensure user safety — a significant concern for consumers who are increasingly looking for non-toxic alternatives.
The timing of this financial bolstering is critical, as the European regulatory landscape for pesticides continues to grow more rigid. The recent ban on certain neurotoxic insecticides in Germany marks a pivotal shift towards stricter guidelines, and similar measures are rolling out across other EU member states. Affix Labs has already secured active substance approvals in several countries including Germany, France, Austria, and Norway. The financial support will facilitate a strategic expansion into these key markets, with plans to subsequently penetrate the markets in the UK and Poland.
In addition to its retail consumer products, Affix Labs is also set to introduce a B2B strategy under the brand
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.